|
Syros Pharmaceuticals Inc (NASDAQ: SYRS) |
|
SYRS's vs. Competition, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
| Syros Pharmaceuticals Inc |
SYRS |
1 |
23 |
-98 |
47 |
| Verona Pharma Plc |
VRNA |
62,641 |
0 |
-164 |
79 |
| Tuhura Biosciences Inc |
HURA |
107 |
0 |
0 |
0 |
| Phathom Pharmaceuticals Inc |
PHAT |
766 |
82 |
-346 |
55 |
| Rein Therapeutics Inc |
RNTX |
41 |
0 |
0 |
0 |
| G1 Therapeutics Inc |
GTHX |
375 |
58 |
-45 |
55 |
| Blueprint Medicines Corporation |
BPMC |
8,513 |
562 |
-156 |
582 |
| Mirati Therapeutics Inc |
MRTX |
3,815 |
38 |
-726 |
450 |
| Zymeworks Inc |
ZYME |
943 |
93 |
-114 |
955 |
| Agios Pharmaceuticals Inc |
AGIO |
1,985 |
36 |
674 |
383 |
| Lipella Pharmaceuticals Inc |
LIPO |
5 |
1 |
-5 |
16 |
| Glycomimetics Inc |
GLYC |
10 |
1 |
-50 |
51 |
| Mersana Therapeutics inc |
MRSN |
46 |
34 |
-74 |
102 |
| Lantern Pharma Inc |
LTRN |
33 |
0 |
-21 |
22 |
| Puretech Health Plc |
PRTC |
5,368 |
3 |
-67 |
118 |
| Milestone Pharmaceuticals Inc |
MIST |
111 |
0 |
-52 |
33 |
| Precigen Inc |
PGEN |
447 |
-2 |
-157 |
99 |
| Day One Biopharmaceuticals Inc |
DAWN |
685 |
162 |
-79 |
49 |
| Shattuck Labs Inc |
STTK |
50 |
6 |
-71 |
202 |
| Jazz Pharmaceuticals Plc |
JAZZ |
6,616 |
4,065 |
482 |
2,800 |
| Alnylam Pharmaceuticals Inc |
ALNY |
39,939 |
2,348 |
-270 |
2,100 |
| Biomarin Pharmaceutical Inc |
BMRN |
11,046 |
2,950 |
524 |
3,401 |
| Vertex Pharmaceuticals Inc |
VRTX |
118,189 |
11,100 |
-989 |
5,400 |
| Deciphera Pharmaceuticals Inc |
DCPH |
2,236 |
175 |
-190 |
355 |
| Xencor Inc |
XNCR |
654 |
127 |
-211 |
280 |
| Zai Lab Limited |
ZLAB |
40,485 |
418 |
-252 |
656 |
| Intercept Pharmaceuticals inc |
ICPT |
794 |
288 |
-62 |
375 |
| Supernus Pharmaceuticals inc |
SUPN |
1,830 |
668 |
62 |
652 |
| Nurix Therapeutics Inc |
NRIX |
997 |
56 |
-208 |
117 |
| Cytodyn inc |
CYDY |
434 |
0 |
-7 |
23 |
| Madrigal Pharmaceuticals Inc |
MDGL |
6,530 |
317 |
-392 |
53 |
| 89bio Inc |
ETNB |
1,524 |
0 |
-387 |
19 |
| Allakos Inc |
ALLK |
30 |
0 |
-71 |
131 |
| Iveric Bio Inc |
ISEE |
5,477 |
0 |
-223 |
105 |
| Kinnate Biopharma Inc |
KNTE |
125 |
0 |
-127 |
99 |
| Terns Pharmaceuticals Inc |
TERN |
355 |
0 |
-90 |
59 |
| Actinium Pharmaceuticals Inc |
ATNM |
45 |
1 |
-38 |
37 |
| Oramed Pharmaceuticals Inc |
ORMP |
87 |
3 |
-28 |
16 |
| Tg Therapeutics Inc |
TGTX |
5,861 |
386 |
39 |
132 |
| Reata Pharmaceuticals Inc |
RETA |
7,154 |
3 |
-88 |
350 |
| Wave Life Sciences Ltd |
WVE |
1,095 |
105 |
-112 |
288 |
| Janux Therapeutics Inc |
JANX |
1,539 |
13 |
-78 |
37 |
| Mira Pharmaceuticals Inc |
MIRA |
19 |
0 |
-8 |
0 |
| Innovation Pharmaceuticals Inc |
CTIX |
0 |
0 |
-3 |
11 |
| Inhibitor Therapeutics Inc |
HPPI |
14 |
0 |
-3 |
5 |
| Regenerx Biopharmaceuticals inc |
RGRX |
0 |
0 |
-2 |
6 |
| Aravive Inc |
ARAV |
3 |
7 |
-40 |
31 |
| Palvella Therapeutics Inc |
PVLA |
276 |
0 |
0 |
0 |
| Tyme Technologies Inc. |
TYME |
54 |
0 |
-24 |
14 |
| Nucana Plc |
NCNA |
6 |
0 |
-28 |
18 |
| Tonix Pharmaceuticals Holding Corp |
TNXP |
190 |
10 |
-132 |
70 |
| Effector Therapeutics Inc |
EFTR |
0 |
0 |
-35 |
47 |
| Affimed N v |
AFMD |
0 |
9 |
-119 |
102 |
| Cadrenal Therapeutics Inc |
CVKD |
17 |
0 |
-11 |
10 |
| Vaccinex Inc |
VCNX |
2 |
-1 |
-19 |
71 |
| Salarius Pharmaceuticals inc |
SLRX |
2 |
5 |
-6 |
8 |
| Panbela Therapeutics Inc |
PBLA |
1 |
0 |
-28 |
26 |
| Paxmedica Inc |
PXMD |
0 |
0 |
-18 |
10 |
| Neubase Therapeutics inc |
NBSE |
1 |
0 |
-14 |
7 |
| Phio Pharmaceuticals Corp |
PHIO |
10 |
0 |
-7 |
10 |
| Cns Pharmaceuticals Inc |
CNSP |
2 |
0 |
-16 |
15 |
| Bolt Biotherapeutics Inc |
BOLT |
234 |
4 |
-63 |
21 |
| Nextcure Inc |
NXTC |
19 |
0 |
-50 |
43 |
| Ibio inc |
IBIO |
9 |
2 |
-22 |
14 |
| Abvc Biopharma Inc |
ABVC |
26 |
1 |
-6 |
29 |
| Whitehawk Therapeutics Inc |
WHWK |
78 |
0 |
0 |
0 |
| I mab |
IMAB |
465 |
4 |
-22 |
0 |
| Kineta Inc |
KANT |
3 |
0 |
-8 |
50 |
| Lumos Pharma Inc |
LUMO |
36 |
2 |
-35 |
23 |
| Alimera Sciences Inc |
ALIM |
301 |
98 |
-15 |
159 |
| Tempest Therapeutics Inc |
TPST |
23 |
0 |
-45 |
18 |
| Werewolf Therapeutics Inc |
HOWL |
55 |
16 |
-72 |
18 |
| Oncternal Therapeutics Inc |
ONCT |
2 |
2 |
-35 |
24 |
| Y mabs Therapeutics inc |
YMAB |
215 |
89 |
-28 |
100 |
| Enliven Therapeutics Inc |
ELVN |
1,097 |
0 |
-95 |
20 |
| Pliant Therapeutics Inc |
PLRX |
84 |
10 |
-220 |
26 |
| Xoma Royalty Corporation |
XOMA |
425 |
43 |
-10 |
13 |
| Protagonist Therapeutics inc |
PTGX |
3,549 |
208 |
56 |
112 |
| Chinook Therapeutics Inc |
KDNY |
2,892 |
6 |
-246 |
79 |
| Rhythm Pharmaceuticals inc |
RYTM |
3,934 |
137 |
-174 |
111 |
| Nuvalent Inc |
NUVL |
5,603 |
4 |
-301 |
142 |
| Spyre Therapeutics Inc |
SYRE |
6 |
6 |
-209 |
31 |
| Adc Therapeutics Sa |
ADCT |
384 |
76 |
-150 |
174 |
| Adagene Inc |
ADAG |
110 |
0 |
-33 |
77 |
| Adlai Nortye Ltd |
ANL |
71 |
5 |
-105 |
50 |
| Rafael Holdings Inc |
RFL |
50 |
1 |
-79 |
18 |
|
SUBTOTAL |
359,251 |
24,867 |
-6,740 |
22,596 |
|
